Biotechnology - Life Science and Biotech Trends for 2026
View as a Web Page
News Medical
 
  Biotechnology Biotechnology logo  
  The latest Biotechnology news from AZoNetwork  
 

e-Fuels: Climate-Friendly Energy That Can Put us in the Driving Seat to a Sustainable Futuree-Fuels: Climate-Friendly Energy That Can Put us in the Driving Seat to a Sustainable Future

Produced through the combination of green hydrogen and captured carbon dioxide, e-fuels represent a versatile and sustainable alternative to traditional fossil fuels. This application note delves into the innovative processes and technologies behind e-fuels, from synthesis gas production to the creation of synthetic methane and Sustainable Aviation Fuel (SAF).

Download the app note
 
   Life Science and Biotech Trends for 2026Life Science and Biotech Trends for 2026
 
Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new regulatory and data challenges by 2026.
 
   What are Biogenic Materials and How are They Used?What are Biogenic Materials and How are They Used?
 
Biogenic materials, from plants to microorganisms, are changing fields like biomedical research and sustainable building with their unique properties.
 
 What Is Bio-Monitoring? The Role of Spectroscopy in Real-Time Analysis
 
What Is Bio-Monitoring? The Role of Spectroscopy in Real-Time AnalysisLearn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, environmental monitoring, and bioprocessing.
 
 
 CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatment
 
CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatmentGenetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism. Transthyretin amyloidosis (ATTR) is a progressive disorder involving amyloid deposits of misfolded transthyretin (TTR) proteins.
 
 
 First topical CRISPR gene therapy corrects disease-causing mutations in human skin
 
First topical CRISPR gene therapy corrects disease-causing mutations in human skinGene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the University of British Columbia are extending those possibilities to the skin for the first time.
 
 
 ERC Proof of Concept grant supports promising CRISPR-based cancer treatment research
 
ERC Proof of Concept grant supports promising CRISPR-based cancer treatment researchMicrobiologist John van der Oost of Wageningen University & Research (WUR) has received an ERC Proof of Concept grant to further develop a promising CRISPR-based approach to cancer treatment. With funding of €150,000, he and researcher Christian Südfeld will spend the next eighteen months working on a method to kill cancer cells from within, while sparing healthy cells as much as possible.
 
 
 New workflow boosts nuclear delivery for safer gene therapy
 
New workflow boosts nuclear delivery for safer gene therapyGene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells. However, to be effective, the new gene must make it into a cell's nucleus.
 
 
 Bioinformatic Framework Reconstructs Evolutionary History of Complex Polyploid Genomes
 
Bioinformatic Framework Reconstructs Evolutionary History of Complex Polyploid GenomesWhole-genome duplication has repeatedly reshaped plant genomes and driven evolutionary innovation, ecological adaptation, and crop diversification.
 
 
 Bioengineered Lymphatic Tissue Shows Promise in Treating Secondary Lymphedema
 
Bioengineered Lymphatic Tissue Shows Promise in Treating Secondary LymphedemaThe rising incidence of cancer worldwide has led to an increasing number of surgeries that involve the removal of lymph nodes.
 
 
 Expanding CRISPR to Tackle Incurable Skin Diseases
 
Expanding CRISPR to Tackle Incurable Skin DiseasesGene-editing techniques such as CRISPR have enabled new treatments for previously incurable diseases. Researchers at the University of British Columbia are now expanding those capabilities to include the skin for the first time.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026